Document_And_Entity_Informatio
Document And Entity Information | 3 Months Ended | |
Mar. 31, 2015 | 12-May-15 | |
Document Information [Line Items] | ||
Entity Registrant Name | Vuzix Corp | |
Entity Central Index Key | 1463972 | |
Current Fiscal Year End Date | -19 | |
Entity Filer Category | Smaller Reporting Company | |
Trading Symbol | VUZI | |
Entity Common Stock, Shares Outstanding | 15,909,978 | |
Document Type | 10-Q | |
Amendment Flag | FALSE | |
Document Period End Date | 31-Mar-15 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2015 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Current Assets | ||
Cash and Cash Equivalents | $22,884,309 | $84,967 |
Accounts Receivable | 255,126 | 383,533 |
Inventories, Net (Note 3) | 1,013,467 | 911,949 |
Prepaid Expenses and Other Assets | 383,136 | 579,000 |
Total Current Assets | 24,536,038 | 1,959,449 |
Tooling and Equipment, Net | 387,263 | 416,965 |
Patents and Trademarks, Net | 419,771 | 423,489 |
Software Development Costs, Net | 716,126 | 787,738 |
Debt Issuance Costs, Net | 101,068 | 112,521 |
Total Assets | 26,160,266 | 3,700,162 |
Current Liabilities | ||
Accounts Payable | 827,988 | 2,183,565 |
Line of Credit | 0 | 112,500 |
Note Payable (Note 4) | 0 | 37,038 |
Current Portion of Long-Term Debt, (Note 7) | 80,097 | 128,425 |
Current Portion of Capital Leases | 11,629 | 16,882 |
Customer Deposits | 19,057 | 120,550 |
Unearned Revenue | 68,489 | 53,403 |
Accrued Expenses (Note 5) | 673,737 | 699,067 |
Income and Other Taxes Payable | 29,098 | 35,158 |
Total Current Liabilities | 1,710,095 | 3,386,588 |
Long-Term Liabilities | ||
Long-Term Derivative Liability (Note 6) | 175,158 | 13,541,138 |
Long-Term Portion of Term Debt, net of discount (Note 7) | 1,077,009 | 1,088,996 |
Long-Term Portion of Accrued Interest | 103,921 | 81,451 |
Total Long-Term Liabilities | 1,356,088 | 14,711,585 |
Total Liabilities | 3,066,183 | 18,098,173 |
Stockholders’ Equity (Deficit) | ||
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 49,626 Shares Issued and Outstanding March 31, 2015, and 0 Shares Outstanding on December 31, 2014 | 50 | 0 |
Common Stock — $.001 Par Value, 100,000,000 Shares Authorized; 15,865,141 Shares Issued and Outstanding March 31, 2015 and 11,295,387 on December 31, 2014 | 15,865 | 11,296 |
Additional Paid-in Capital | 72,330,410 | 29,752,083 |
Accumulated Deficit | -49,252,242 | -44,161,390 |
Total Stockholders’ Equity (Deficit) | 23,094,083 | -14,398,011 |
Total Liabilities and Stockholders’ Equity (Deficit) | $26,160,266 | $3,700,162 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Preferred Stock, Par Value | $0.00 | $0.00 |
Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 |
Preferred Stock, Shares Issued | 49,626 | |
Preferred Stock, Shares Outstanding | 49,626 | 0 |
Common Stock, Par Value | $0.00 | $0.00 |
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, Shares Issued | 15,865,141 | 11,295,387 |
Common Stock, Shares Outstanding | 15,865,141 | 11,295,387 |
CONSOLIDATED_STATEMENT_OF_CHAN
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $) | Total | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Preferred Stock |
Balance at Dec. 31, 2014 | ($14,398,011) | $11,296 | $29,752,083 | ($44,161,390) | $0 |
Balance (in shares) at Dec. 31, 2014 | 11,295,387 | 0 | |||
Stock Compensation Expense | 113,084 | 113,084 | |||
Conversion of Note Payable | 337,500 | 150 | 337,350 | ||
Conversion of Note Payable (in shares) | 150,000 | ||||
Stock Issues for Services | 235,500 | 40 | 235,460 | ||
Stock Issues for Services (in shares) | 40,000 | ||||
Common Stock Awards to Officers, Directors and Law Firm | 1,475,000 | 295 | 1,474,705 | ||
Common Stock Awards to Officers, Directors and Law Firm (in Shares) | 295,000 | ||||
Warrants Issued for Services | 260,373 | 260,373 | |||
Exercise of Warrants | 1,200,751 | 4,084 | 1,196,667 | ||
Exercise of Warrants (in shares) | 4,084,754 | ||||
Reclass Fair Value of Warrant Derivative Liability upon Exercise | 2,826,053 | 2,826,053 | |||
Reclass Fair Value of Warrant Derivative Liability Upon Waiver of Certain Anti-Dilutive Provisions | 8,736,412 | 8,736,412 | |||
Reclass Fair Value of Note Derivative Liability Upon Waiver of Certain Anti-Dilutive Provisions | 2,806,942 | 2,806,942 | |||
Proceeds from Preferred Stock Offering | 24,813,000 | 24,812,950 | 50 | ||
Proceeds from Preferred Stock Offering (in Shares) | 49,626 | ||||
Direct costs of preferred stock Offering | -221,669 | -221,669 | |||
Net Loss | -5,090,852 | -5,090,852 | |||
Balance at Mar. 31, 2015 | $23,094,083 | $15,865 | $72,330,410 | ($49,252,242) | $50 |
Balance (in shares) at Mar. 31, 2015 | 15,865,141 | 49,626 |
CONDENSED_CONSOLIDATED_STATEME
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Sales of Products | $695,574 | $649,418 |
Sales of Engineering Services | 113,581 | 149,000 |
Total Sales | 809,155 | 798,418 |
Cost of Sales — Products | 585,390 | 390,649 |
Cost of Sales — Engineering Services | 45,432 | 59,600 |
Total Cost of Sales | 630,822 | 450,249 |
Gross Profit | 178,333 | 348,169 |
Operating Expenses: | ||
Research and Development | 514,707 | 397,422 |
Selling and Marketing | 357,547 | 364,555 |
General and Administrative | 2,934,907 | 479,637 |
Depreciation and Amortization | 59,638 | 99,705 |
Total Operating Expenses | 3,866,799 | 1,341,319 |
(Loss) from Operations | -3,688,466 | -993,150 |
Other Income (Expense) | ||
Other Taxes | -11,774 | -21,442 |
Foreign Exchange Gain (Loss) | 5,271 | -3,951 |
Gain (Loss) on Derivative Valuation | -1,003,427 | 2,575,262 |
Amortization of Term Debt Discount | -340,960 | -6,326 |
Interest Expense | -51,496 | -38,487 |
Total Other Income (Expense) | -1,402,386 | 2,505,056 |
Income (Loss) Before Provision for Income Taxes | -5,090,852 | 1,511,906 |
Provision (Benefit) for Income Taxes | 0 | 0 |
Net Income (Loss) | -5,090,852 | 1,511,906 |
Preferred Stock Dividends | -358,939 | 0 |
Earnings Available to Common Shareholders | ($5,449,791) | $1,511,906 |
Earnings (Loss) per Share (Note 2) | ||
Basic | ($0.40) | $0.15 |
Diluted | ($0.40) | $0.13 |
Weighted-average Shares Outstanding: | ||
Basic | 13,561,206 | 9,972,105 |
Diluted | 13,561,206 | 11,517,104 |
CONDENSED_CONSOLIDATED_STATEME1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Cash Flows from Operating Activities | ||
Net Income (Loss) | ($5,090,852) | $1,511,906 |
Non-Cash Adjustments | ||
Depreciation and Amortization | 59,639 | 99,705 |
Amortization of Software Development Costs in cost of sales products | 71,613 | 0 |
Common Stock Awards Compensation Expense | 1,475,000 | 0 |
Stock-Based Option Compensation Expense | 113,084 | 19,347 |
Amortization of Term Debt Discount | 340,960 | 6,326 |
Amortization of Debt Issuance Costs | 11,453 | 0 |
Common Stock and Warrants Issued for Services | 526,916 | 0 |
(Gain) Loss on Derivative Valuation | 1,003,427 | -2,575,262 |
(Increase) Decrease in Operating Assets | ||
Accounts Receivable | 128,407 | 27,130 |
Inventories | -101,518 | -82,047 |
Prepaid Expenses and Other Assets | 164,821 | 136,026 |
Increase (Decrease) in Operating Liabilities | ||
Accounts Payable | -1,355,578 | -146,719 |
Accrued Expense | -25,330 | -13,700 |
Customer Deposits | -101,493 | -72,409 |
Unearned Revenue | 15,086 | 0 |
Income and Other Taxes Payable | -6,060 | 10,678 |
Accrued Interest | 22,470 | 5,708 |
Net Cash Flows Used in From Operating Activities | -2,747,955 | -1,073,311 |
Cash Flows from Investing Activities | ||
Purchases of Tooling and Equipment | -18,310 | -57,009 |
Investments in Software | 0 | -280,585 |
Investments in Patents and Trademarks | -7,909 | -11,305 |
Net Cash Used in Investing Activities | -26,219 | -348,899 |
Cash Flows from Financing Activities | ||
Proceeds from Exercise of Warrants | 1,200,751 | 1,447,425 |
Repayment of Capital Leases | -5,253 | -8,042 |
Repayment of Long-Term Debt and Notes Payable | -100,813 | -55,501 |
Proceeds from Preferred Stock Offering | 24,813,000 | 0 |
Issuance Costs on Preferred Stock Offering | -221,669 | 0 |
Net Change in Lines of Credit | -112,500 | 0 |
Net Cash Flows Provided by Financing Activities | 25,573,516 | 1,383,882 |
Net Increase (Decrease) in Cash and Cash Equivalents | 22,799,342 | -38,328 |
Cash and Cash Equivalents — Beginning of Period | 84,967 | 310,140 |
Cash and Cash Equivalents — End of Period | 22,884,309 | 271,812 |
Supplemental Disclosures | ||
Interest Paid | 17,794 | 32,779 |
Common Stock and Warrants Issued for Services, Classified as Prepaid Expense | 138,625 | 0 |
Conversion of Long-Term Debt | 337,500 | 0 |
Reclassification of Derivative Liability to Paid-In Capital upon Waiver of Certain Anti-Dilutive Provisions of Warrants and Convertible Debt | 11,543,354 | 0 |
Reclassification of Derivative Liability Upon Warrant Exercises | $2,826,053 | $0 |
Basis_of_Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation Of Financial Statements [Abstract] | |
Basis of Presentation | Note 1 — Basis of Presentation |
The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2014 was derived from the audited Consolidated Financial Statements in Form 10-K. | |
The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2014, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission. | |
The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. | |
Earnings_Loss_Per_Share
Earnings (Loss) Per Share | 3 Months Ended |
Mar. 31, 2015 | |
Earnings (Loss) Per Share | |
Earnings (Loss) Per Share | Note 2 – Earnings (Loss) Per Share |
Basic earnings (loss) per share is computed by dividing net income or loss by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of any convertible debt and convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Since the Company reported a net loss for the three months ended March 31, 2015, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. Since the Company reported net income for the three months ended March 31, 2014, a total of 1,544,999 additional shares have been included for these diluted calculations. As of March 31, 2015 and December 31, 2014, there were 7,186,350 and 7,012,767 respectively, common stock share equivalents potentially issuable under convertible debt agreements, conversion of preferred shares, options, and warrants that could potentially dilute basic earnings per share in the future. | |
Inventories_Net
Inventories, Net | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Inventory Disclosure [Abstract] | ||||||||
Inventories, Net | Note 3 — Inventories, Net | |||||||
Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following as at March 31, 2015 and December 31, 2014: | ||||||||
March 31, 2015 | December 31, 2014 | |||||||
Purchased Parts and Components | $ | 923,363 | $ | 1,251,224 | ||||
Work in Process | 14,702 | 25,974 | ||||||
Finished Goods | 405,577 | 300,889 | ||||||
Less: Reserve for Obsolescence | -330,175 | -666,138 | ||||||
Net | $ | 1,013,467 | $ | 911,949 | ||||
Notes_Payable
Notes Payable | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Notes Payable [Abstract] | ||||||||
Notes Payable | Note 4 — Notes Payable | |||||||
Notes payable represent promissory notes payable by the Company. | ||||||||
March 31, 2015 | December 31, 2014 | |||||||
Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand. The notes bear interest at 18.5% and secured by all the assets of the Company. | $ | — | $ | 37,038 | ||||
$ | — | $ | 37,038 | |||||
Accrued_Expenses
Accrued Expenses | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Payables and Accruals [Abstract] | ||||||||
Accrued Expenses | Note 5 — Accrued Expenses | |||||||
Accrued expenses consisted of the following: | ||||||||
March 31, 2015 | December 31, 2014 | |||||||
Accrued Wages and Related Costs | $ | 91,134 | $ | 101,445 | ||||
Accrued Compensation | 417,286 | 428,786 | ||||||
Accrued Professional Services | 33,500 | 45,000 | ||||||
Accrued Warranty Obligations | 45,623 | 39,624 | ||||||
Accrued Interest | 85,191 | 75,471 | ||||||
Other Accrued Expenses | 1,003 | 8,741 | ||||||
Total | $ | 673,737 | $ | 699,067 | ||||
Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding. These amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8% per annum, compounding monthly. The amounts were $386,036 as of March 31, 2015 and $393,526 as of December 31, 2014. The related interest amounts included in Accrued Interest were $71,076 and $62,801 respectively as of March 31, 2015 and December 31, 2014. The related interest expense amounts for the three months ended March 31, 2015 and 2014 were $8,994 and $7,338 respectively. | ||||||||
The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2015 were as follows: | ||||||||
Accrued Warranty Obligations at December 31, 2014 | $ | 39,624 | ||||||
Reductions for Settling Warranties | -21,948 | |||||||
Warranties Issued During Period | 27,947 | |||||||
Accrued Warranty Obligations at March 31, 2015 | $ | 45,623 | ||||||
Derivative_Liability_and_Fair_
Derivative Liability and Fair Value Measurements | 3 Months Ended | |||||||||||||
Mar. 31, 2015 | ||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||
Derivative Liability and Fair Value Measurements | Note 6 – Derivative Liability and Fair Value Measurements | |||||||||||||
The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the public equity offering and related debt conversions on August 5, 2013. These warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date. | ||||||||||||||
Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. As at March 31, 2015 a total of 52,600 of these warrants were outstanding and as at December 31, 2014 a total of 4,730,992 warrants were outstanding that contained a full-ratchet anti-dilution provision. In connection with the Series A Private Placement on January 2, 2015 (see Note 9), holders of approximately 86% of outstanding warrants issued by the Company in its public offering and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering(collectively, the “Public Offering Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the Public Offering Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the Public Offering Warrants (the “Public Offering Warrant Waiver”). As a result the related derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-In Capital. | ||||||||||||||
The Company recognized a derivative liability during the year ended December 31, 2014 for the $3,000,000 of senior convertible notes with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with FASB ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $1,938,988. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Liabilities section of the balance sheet which is amortized into interest expense over the term of the related note. At the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value through earnings. | ||||||||||||||
In connection with the Series A Private Placement on January 2, 2015, each of the holders of notes issued by the Company on June 3, 2014 (the “June 2014 Notes”) agreed to irrevocably waive their rights to anti-dilution protection under Section 5(b) of the June 2014 Notes in the event the Company issues additional securities at a per share price lower than the conversion price of the June 2014 Notes (the “June 2014 Note Waiver”). As a result this derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-In Capital. For period ending December 31, 2014, the Monte Carlo Options Lattice pricing model was used to estimate the fair value of the embedded conversion option on the convertible notes issued during this period. | ||||||||||||||
The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. | ||||||||||||||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: | ||||||||||||||
- Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; | ||||||||||||||
- Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and | ||||||||||||||
- Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. | ||||||||||||||
The Company’s financial instruments primarily consists of cash and cash equivalents, accounts receivable, accounts payable, lines of credit, long-term debt and capital leases, customer deposits, accrued expenses, and income taxes payable. | ||||||||||||||
As of the consolidated balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented due to both the short maturities of these instruments and that the interest rates on borrowing approximate those that would have been available for loans for similar remaining maturity and risk profiles. | ||||||||||||||
We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at March 31, 2015: | ||||||||||||||
Total | (Level 1) | (Level 2) | Level (3) | |||||||||||
Assets | $ | — | $ | — | $ | — | $ | — | ||||||
Total assets measured at fair value | — | — | — | — | ||||||||||
Liabilities | ||||||||||||||
Note Conversion Feature Liability | — | — | — | — | ||||||||||
Warrant Liability | 175,158 | — | — | 175,158 | ||||||||||
Total liabilities measured at fair value (Long-Term) | $ | 175,158 | $ | — | $ | — | $ | 175,158 | ||||||
We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2014: | ||||||||||||||
Total | (Level 1) | (Level 2) | Level (3) | |||||||||||
Assets | $ | — | $ | — | $ | — | $ | — | ||||||
Total assets measured at fair value | — | — | — | — | ||||||||||
Liabilities | ||||||||||||||
Note Conversion Feature Liability | 2,806,942 | — | — | 2,806,942 | ||||||||||
Warrant Liability | 10,734,196 | — | — | 10,734,196 | ||||||||||
Total liabilities measured at fair value (Long-Term) | $ | 13,541,138 | $ | — | $ | — | $ | 13,541,138 | ||||||
Fair value – December 31, 2014 | 13,541,138 | |||||||||||||
Reclassification of warrant exercises to Additional Paid-in Capital | -2,826,053 | |||||||||||||
Change in fair value for the period of warrant derivative liability | 1,003,427 | |||||||||||||
Reclassification of embedded debt conversion price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions | -2,806,942 | |||||||||||||
Reclassification of warrant exercise price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions | -8,736,412 | |||||||||||||
Fair value – March 31, 2015 | $ | 175,158 | ||||||||||||
The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrant liability outstanding: | ||||||||||||||
March 31, 2015 | December 31, 2014 | |||||||||||||
Assumptions for Pricing Model: | ||||||||||||||
Expected term in years | 3.35 to 3.59 | 3.59 to 3.78 | ||||||||||||
Volatility range for years | 89 to 90% | 81 to 89% | ||||||||||||
Risk-free interest rate | 0.89 to 1.06% | 0.83 to 1.11% | ||||||||||||
Expected annual dividends | None | None | ||||||||||||
Value of warrants outstanding: | ||||||||||||||
Fair value of warrants | $ | 175,158 | $ | 10,734,196 | ||||||||||
LongTerm_Debt
Long-Term Debt | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Long-Term Debt | Note 7 — Long-Term Debt | |||||||
Long-term debt consisted of the following: | ||||||||
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate. | 130,836 | 186,131 | ||||||
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal. | -40,074 | -46,399 | ||||||
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company. | 42,395 | 50,874 | ||||||
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required. The notes carry a 5% interest, payable upon the note’s maturity. Both the interest plus accrued interest is convertible into shares of the Company’s common shares at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company. | 2,037,500 | 2,375,000 | ||||||
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. | -1,013,551 | -1,348,185 | ||||||
$ | 1,157,106 | $ | 1,217,421 | |||||
Less: Amount Due Within One Year | -80,097 | -128,425 | ||||||
Amount Due After One Year | $ | 1,077,009 | $ | 1,088,996 | ||||
The calendar year aggregate maturities for all long-term borrowings exclusive of discounts as of March 31, 2015 are as follows: | ||||||||
Total Aggregate Maturity For Period | Amounts | |||||||
2015 | $ | 114,088 | ||||||
2016 | 59,143 | |||||||
2017 | 2,037,500 | |||||||
Total Required Principal Payments Exclusive of Debt Discounts | 2,210,731 | |||||||
Total Unamortized Debt Discounts | -1,053,625 | |||||||
Total Net Long-Term Borrowings as of March 31, 2015 | $ | 1,157,106 | ||||||
Income_Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2015 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 8 — Income Taxes |
The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets. | |
Preferred_Stock
Preferred Stock | 3 Months Ended |
Mar. 31, 2015 | |
Equity [Abstract] | |
Preferred Stock | Note 9 — Preferred Stock |
The Company may issue shares of undesignated preferred stock in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine the voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred stock are authorized as of March 31, 2015 and December 31, 2014. | |
On January 2, 2015 (the “Series A Closing Date”), we entered into and closed a Series A Preferred Stock Purchase Agreement (the “Series A Purchase Agreement”) with Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold to the Series A Purchaser, an aggregate of 49,626 shares of the Company’s Series A Preferred Stock, at a purchase price of $500 per share, for an aggregate purchase price of $24,813,000 (the “Series A Private Placement”). Each share of Series A Preferred Stock is convertible, at the option of the Series A Purchaser, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations). Total costs incurred connection with this offering were approximately $222,000. | |
Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6% per annum, compounded quarterly and payable in cash or in kind, at the Company’s sole discretion. In the event of the liquidation, dissolution or winding up of the Company, each share of Series A Preferred Stock is entitled to a liquidation preference equal to one times (1x) the Series A Purchaser’s original per share purchase price, plus a right to receive an additional liquidation distribution together with the common stock holders pro rata on an as converted basis, but not in excess of $1,000 per share in the aggregate (subject to adjustment for accrued but unpaid dividends and in the event of stock splits, dividends or other combinations). Each share of Series A Preferred Stock is entitled to vote with the holders of the Company’s common stock on matters presented to its stockholders, and is entitled to cast such number of votes equal to the whole number of shares of common stock into which such shares of Series A Preferred Stock are convertible. The holders of record of the Series A Preferred Stock will be entitled to nominate and elect 2 directors to the Company’s Board of Directors (the “Board Election Right”), at least one of whom will be required to qualify as an “independent” director, as that term is used in applicable exchange listing rules. The Board Election Right with respect to the independent director will terminate on such date as the number of shares of Series A Preferred Stock then outstanding is less than 40% of the original amount purchased by the Series A Purchaser. The Board Election Right with respect to the second director shall terminate on such date as the number of shares of Series A Preferred Stock then outstanding is less than 20% of the original amount purchased by the Series A Purchaser. The Company also granted the Series A Purchaser the right to have a board observer at meetings of the Company’s Board of Directors and committees thereof. | |
For as long as at least 25% (or 12,406 shares) of the Series A Preferred Stock is outstanding, the Company may not, without the consent of holders of at least 60% of the then outstanding shares of Series A Preferred Stock, take certain actions, including but not limited to: (i) liquidate, dissolve, or wind up the business and affairs of the Company; (ii) amend, alter or repeal any provision of its charter or bylaws in a manner that adversely effects the rights of the Series A Preferred Stock; (iii) create or issue any capital stock that is equal to or senior to the Series A Preferred Stock with respect to preferences; (iv) create or issue any debt security, subject to certain exceptions; (v) pay off any debt obligation prior to its stated maturity date; or (vi) enter into any stockholders rights plan or similar arrangement or take other actions that may limit actions that holders of a majority of the Series A Preferred Stock can take under Section 203 (“Section 203”) of the Delaware General Corporation Law, as well as such other customary provisions protecting the rights of the holder of the Series A Preferred Stock, as are outlined in the Certificate of Designation. | |
The Series A Purchaser has the right to participate in any proposed issuance by the Company of its securities, subject to certain exceptions (the “Participation Right”). In the event the Series A Purchaser is not afforded the opportunity to exercise its Participation Right, the Series A Purchaser will have the right, but not the obligation, up to two times per calendar year, to acquire additional securities from the Company in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing. | |
In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering all shares of common stock issuable upon conversion of the Series A Preferred Stock sold in the Series A Private Placement on or before February 14, 2015. The Company filed the registration statement on February 12, 2015 and the registration statement was declared effective by SEC on February 17, 2015. | |
Stock_Warrants
Stock Warrants | 3 Months Ended | ||||
Mar. 31, 2015 | |||||
Stockholders' Equity Note [Abstract] | |||||
Stock Warrants | Note 10 — Stock Warrants | ||||
A summary of the various changes in warrants during the three-month period ended March 31, 2015 is as follows. | |||||
Number of Shares | |||||
Warrants Outstanding at December 31, 2014 | 5,236,660 | ||||
Exercised During the Period | -4,699,017 | ||||
Issued During the Period | 60,000 | ||||
Expired During the Period | — | ||||
Warrants Outstanding, March 31, 2015 | 597,643 | ||||
The outstanding warrants as of March 31, 2015 expire from May 21, 2015 to August 5, 2018. The weighted average remaining term of the warrants is 2.9 years. The weighted average exercise price is $2.56 per share. | |||||
The Black-Scholes-Merton pricing model was used to estimate the fair value of share-based awards under FASB ASC Topic 718. The Black-Scholes-Merton pricing model incorporates various and highly subjective assumptions, including expected term and expected volatility. | |||||
The following shows the assumptions used to compute the fair value of warrants granted during the three period ending March 31, 2015 for investor relations services and their estimated value: | |||||
⋅ Expected term in years 2.8 to 3.0 years | |||||
⋅ Volatility 122.8 to 122.9% | |||||
⋅ Risk-free interest rate 0.90 to 0.99% | |||||
⋅ Expected annual dividends None | |||||
⋅ Fair value of warrants issued $260,373 | |||||
Unrecognized warrant-based compensation expense was approximately $61,082 as of March 31, 2015, relating to the unamortized period of services remaining under the arrangements for which the warrants were issued. The entire unamortized amount will be recognized in the second quarter ending June 30, 2015. | |||||
Stock_Option_Plans
Stock Option Plans | 3 Months Ended | ||||||||||
Mar. 31, 2015 | |||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||
Stock Option Plans | Note 11 — Stock Option Plans | ||||||||||
A summary of stock option activity for the three months ended March 31, 2015 is as follows: | |||||||||||
Weighted | |||||||||||
Number of | Average | Exercise Price | |||||||||
Shares | Exercise Price | Range | |||||||||
Outstanding at December 31, 2014 | 720,551 | $ | 4.46 | $ | 1.71 – $ 17.50 | ||||||
Granted | — | $ | — | $ | — | ||||||
Exercised | — | $ | — | $ | — | ||||||
Expired or Forfeited | — | $ | — | $ | — | ||||||
Outstanding at March 31, 2015 | 720,551 | $ | 4.46 | $ | 1.71 – $ 17.50 | ||||||
As of March 31, 2015, there were 304,337 options that were fully vested and exercisable at a weighted average exercise price of $6.95 per share. The weighted average remaining contractual term on the vested options is 6.9 years. | |||||||||||
As of March 31, 2015 there were 416,214 unvested options exercisable at a weighted average exercise price of $2.63 per share. The weighted average remaining contractual term on the unvested options is 9.3 years. | |||||||||||
No cash was received from option exercises for the three months ended March 31, 2015 and 2014. | |||||||||||
The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At March 31, 2015, the Company had approximately $957,291 of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 2.0 years. | |||||||||||
Litigation
Litigation | 3 Months Ended |
Mar. 31, 2015 | |
Litigation Disclosure [Abstract] | |
Litigation | Note 12 — Litigation |
We are not currently involved in any pending legal proceeding or litigation. | |
Contractual_Obligations
Contractual Obligations | 3 Months Ended |
Mar. 31, 2015 | |
Contractual Obligations [Abstract] | |
Contractual Obligations | Note 13 — Contractual Obligations |
The Company leases office and manufacturing space under operating leases that expire on September 30, 2015 through to March 1, 2016. The Company’s total contractual payment obligations for operating leases as of March 31, 2015 total $66,800. | |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2015 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | Note 14 — Recent Accounting Pronouncements |
FASB ASU 2015-1, Income Statement—Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items This ASU eliminates from GAAP the concept of extraordinary items. ASU 2015-1 is effective for the annual period ending after December 15, 2015. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. | |
FASB ASU 2015-03—Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. This ASU requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability (same treatment as debt discounts). ASU 2015-3 is effective for the annual periods beginning after December 15, 2015. Early adoption is permitted for financial statements that not have been previously issued. | |
There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements. | |
Inventories_Net_Tables
Inventories, Net (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Inventory Disclosure [Abstract] | ||||||||
Schedule of Inventories | Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following as at March 31, 2015 and December 31, 2014: | |||||||
March 31, 2015 | December 31, 2014 | |||||||
Purchased Parts and Components | $ | 923,363 | $ | 1,251,224 | ||||
Work in Process | 14,702 | 25,974 | ||||||
Finished Goods | 405,577 | 300,889 | ||||||
Less: Reserve for Obsolescence | -330,175 | -666,138 | ||||||
Net | $ | 1,013,467 | $ | 911,949 | ||||
Notes_Payable_Tables
Notes Payable (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Notes Payable [Abstract] | ||||||||
Notes payable represent promissory notes payable | Notes payable represent promissory notes payable by the Company. | |||||||
March 31, 2015 | December 31, 2014 | |||||||
Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand. The notes bear interest at 18.5% and secured by all the assets of the Company. | $ | — | $ | 37,038 | ||||
$ | — | $ | 37,038 | |||||
Accrued_Expenses_Tables
Accrued Expenses (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Payables and Accruals [Abstract] | ||||||||
Components of Accrued Expenses | Accrued expenses consisted of the following: | |||||||
March 31, 2015 | December 31, 2014 | |||||||
Accrued Wages and Related Costs | $ | 91,134 | $ | 101,445 | ||||
Accrued Compensation | 417,286 | 428,786 | ||||||
Accrued Professional Services | 33,500 | 45,000 | ||||||
Accrued Warranty Obligations | 45,623 | 39,624 | ||||||
Accrued Interest | 85,191 | 75,471 | ||||||
Other Accrued Expenses | 1,003 | 8,741 | ||||||
Total | $ | 673,737 | $ | 699,067 | ||||
Changes in Accrued Warranty Obligations | The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2015 were as follows: | |||||||
Accrued Warranty Obligations at December 31, 2014 | $ | 39,624 | ||||||
Reductions for Settling Warranties | -21,948 | |||||||
Warranties Issued During Period | 27,947 | |||||||
Accrued Warranty Obligations at March 31, 2015 | $ | 45,623 | ||||||
Derivative_Liability_and_Fair_1
Derivative Liability and Fair Value Measurements (Tables) | 3 Months Ended | |||||||||||||
Mar. 31, 2015 | ||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis | We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at March 31, 2015: | |||||||||||||
Total | (Level 1) | (Level 2) | Level (3) | |||||||||||
Assets | $ | — | $ | — | $ | — | $ | — | ||||||
Total assets measured at fair value | — | — | — | — | ||||||||||
Liabilities | ||||||||||||||
Note Conversion Feature Liability | — | — | — | — | ||||||||||
Warrant Liability | 175,158 | — | — | 175,158 | ||||||||||
Total liabilities measured at fair value (Long-Term) | $ | 175,158 | $ | — | $ | — | $ | 175,158 | ||||||
We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2014: | ||||||||||||||
Total | (Level 1) | (Level 2) | Level (3) | |||||||||||
Assets | $ | — | $ | — | $ | — | $ | — | ||||||
Total assets measured at fair value | — | — | — | — | ||||||||||
Liabilities | ||||||||||||||
Note Conversion Feature Liability | 2,806,942 | — | — | 2,806,942 | ||||||||||
Warrant Liability | 10,734,196 | — | — | 10,734,196 | ||||||||||
Total liabilities measured at fair value (Long-Term) | $ | 13,541,138 | $ | — | $ | — | $ | 13,541,138 | ||||||
Schedule of Fair Value Level 3 warrant liabilities | Fair value – December 31, 2014 | 13,541,138 | ||||||||||||
Reclassification of warrant exercises to Additional Paid-in Capital | -2,826,053 | |||||||||||||
Change in fair value for the period of warrant derivative liability | 1,003,427 | |||||||||||||
Reclassification of embedded debt conversion price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions | -2,806,942 | |||||||||||||
Reclassification of warrant exercise price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions | -8,736,412 | |||||||||||||
Fair value – March 31, 2015 | $ | 175,158 | ||||||||||||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques | The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrant liability outstanding: | |||||||||||||
March 31, 2015 | December 31, 2014 | |||||||||||||
Assumptions for Pricing Model: | ||||||||||||||
Expected term in years | 3.35 to 3.59 | 3.59 to 3.78 | ||||||||||||
Volatility range for years | 89 to 90% | 81 to 89% | ||||||||||||
Risk-free interest rate | 0.89 to 1.06% | 0.83 to 1.11% | ||||||||||||
Expected annual dividends | None | None | ||||||||||||
Value of warrants outstanding: | ||||||||||||||
Fair value of warrants | $ | 175,158 | $ | 10,734,196 | ||||||||||
LongTerm_Debt_Tables
Long-Term Debt (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Components of Long-Term Debt | Long-term debt consisted of the following: | |||||||
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate. | 130,836 | 186,131 | ||||||
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal. | -40,074 | -46,399 | ||||||
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company. | 42,395 | 50,874 | ||||||
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required. The notes carry a 5% interest, payable upon the note’s maturity. Both the interest plus accrued interest is convertible into shares of the Company’s common shares at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company. | 2,037,500 | 2,375,000 | ||||||
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. | -1,013,551 | -1,348,185 | ||||||
$ | 1,157,106 | $ | 1,217,421 | |||||
Less: Amount Due Within One Year | -80,097 | -128,425 | ||||||
Amount Due After One Year | $ | 1,077,009 | $ | 1,088,996 | ||||
Aggregate maturities for all long-term borrowings | The calendar year aggregate maturities for all long-term borrowings exclusive of discounts as of March 31, 2015 are as follows: | |||||||
Total Aggregate Maturity For Period | Amounts | |||||||
2015 | $ | 114,088 | ||||||
2016 | 59,143 | |||||||
2017 | 2,037,500 | |||||||
Total Required Principal Payments Exclusive of Debt Discounts | 2,210,731 | |||||||
Total Unamortized Debt Discounts | -1,053,625 | |||||||
Total Net Long-Term Borrowings as of March 31, 2015 | $ | 1,157,106 | ||||||
Stock_Warrants_Tables
Stock Warrants (Tables) | 3 Months Ended | ||||
Mar. 31, 2015 | |||||
Stockholders' Equity Note [Abstract] | |||||
Changes in Warrants | A summary of the various changes in warrants during the three-month period ended March 31, 2015 is as follows. | ||||
Number of Shares | |||||
Warrants Outstanding at December 31, 2014 | 5,236,660 | ||||
Exercised During the Period | -4,699,017 | ||||
Issued During the Period | 60,000 | ||||
Expired During the Period | — | ||||
Warrants Outstanding, March 31, 2015 | 597,643 | ||||
Stock_Option_Plans_Tables
Stock Option Plans (Tables) | 3 Months Ended | ||||||||||
Mar. 31, 2015 | |||||||||||
Stock Option Plans [Abstract] | |||||||||||
Stock option plans | A summary of stock option activity for the three months ended March 31, 2015 is as follows: | ||||||||||
Weighted | |||||||||||
Number of | Average | Exercise Price | |||||||||
Shares | Exercise Price | Range | |||||||||
Outstanding at December 31, 2014 | 720,551 | $ | 4.46 | $ | 1.71 – $ 17.50 | ||||||
Granted | — | $ | — | $ | — | ||||||
Exercised | — | $ | — | $ | — | ||||||
Expired or Forfeited | — | $ | — | $ | — | ||||||
Outstanding at March 31, 2015 | 720,551 | $ | 4.46 | $ | 1.71 – $ 17.50 | ||||||
Earnings_Loss_Per_Share_Additi
Earnings (Loss) Per Share (Additional Information) (Detail) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,544,999 | ||
Earnings Per Share, Potentially Dilutive Securities | 7,186,350 | 7,012,767 |
Inventories_Net_Components_of_
Inventories, Net (Components of Inventories) (Detail) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Inventory Disclosure [Line Items] | ||
Purchased Parts and Components | $923,363 | $1,251,224 |
Work in Process | 14,702 | 25,974 |
Finished Goods | 405,577 | 300,889 |
Less: Reserve for Obsolescence | -330,175 | -666,138 |
Net | $1,013,467 | $911,949 |
Notes_Payable_Notes_Payable_Re
Notes Payable (Notes Payable Represent Promissory Notes) (Detail) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Notes and Promissory Notes [Line Items] | ||
Notes Payable | $0 | $37,038 |
Officer and Shareholders [Member] | ||
Notes and Promissory Notes [Line Items] | ||
Notes Payable | $0 | $37,038 |
Notes_Payable_Notes_Payable_Re1
Notes Payable (Notes Payable Represent Promissory Notes) (Parenthetical) (Detail) (Officer and Shareholders [Member]) | Mar. 31, 2015 |
Officer and Shareholders [Member] | |
Notes and Promissory Notes [Line Items] | |
Interest percentage | 18.50% |
Accrued_Expenses_Components_of
Accrued Expenses (Components of Accrued Expenses) (Detail) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Accrued Liabilities [Line Items] | ||
Accrued Wages and Related Costs | $91,134 | $101,445 |
Accrued Compensation | 417,286 | 428,786 |
Accrued Professional Services | 33,500 | 45,000 |
Accrued Warranty Obligations | 45,623 | 39,624 |
Accrued Interest | 85,191 | 75,471 |
Other Accrued Expenses | 1,003 | 8,741 |
Total | $673,737 | $699,067 |
Accrued_Expenses_Changes_in_Ac
Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) (USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Class Of Warrant Or Right [Line Items] | |
Accrued Warranty Obligations , begining balance | $39,624 |
Reductions for Settling Warranties | -21,948 |
Warranties Issued During Period | 27,947 |
Accrued Warranty Obligations , Ending balance | $45,623 |
Accrued_Expenses_Additional_In
Accrued Expenses - Additional Information (Detail) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Dec. 31, 2014 | |
Officers Compensation Payable Compounding Monthly Interest Rate | 8.00% | |
Employee-related Liabilities, Current | $386,036 | $393,526 |
Interest Payable | 71,076 | 62,801 |
Interest Payable, Current | $8,994 | $7,338 |
Derivative_Liability_and_Fair_2
Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | $0 | $0 |
Total assets measured at fair value | 0 | 0 |
Note Conversion Feature Liability | 0 | 2,806,942 |
Warrant Liability | 175,158 | 10,734,196 |
Total liabilities measured at fair value (Long-Term) | 175,158 | 13,541,138 |
Fair Value, Inputs, Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Total assets measured at fair value | 0 | 0 |
Note Conversion Feature Liability | 0 | 0 |
Warrant Liability | 0 | 0 |
Total liabilities measured at fair value (Long-Term) | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Total assets measured at fair value | 0 | 0 |
Note Conversion Feature Liability | 0 | 0 |
Warrant Liability | 0 | 0 |
Total liabilities measured at fair value (Long-Term) | 0 | 0 |
Fair Value, Inputs, Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Total assets measured at fair value | 0 | 0 |
Note Conversion Feature Liability | 0 | 2,806,942 |
Warrant Liability | 175,158 | 10,734,196 |
Total liabilities measured at fair value (Long-Term) | $175,158 | $13,541,138 |
Derivative_Liability_and_Fair_3
Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) (Warrant Liabilities [Member], USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Warrant Liabilities [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair value -beginning of period | $13,541,138 |
Reclassification of warrant exercises to Additional Paid-in Capital | -2,826,053 |
Change in fair value for the period of warrant derivative liability | 1,003,427 |
Reclassification of embedded debt conversion price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions | -2,806,942 |
Reclassification of warrant exercise price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions | -8,736,412 |
Fair value - end of period | $175,158 |
Derivative_Liability_and_Fair_4
Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) (Monte Carlo Options Lattice Pricing Model Warrants Outstanding [Member], USD $) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2015 | Dec. 31, 2014 | |
Value of warrants outstanding: | ||
Fair value of warrants | 175,158 | 10,734,196 |
Minimum [Member] | ||
Assumptions for Pricing Model: | ||
Expected term in years | 3 years 4 months 6 days | 3 years 7 months 2 days |
Volatility range for years | 89.00% | 81.00% |
Risk-free interest rate | 0.89% | 0.83% |
Maximum [Member] | ||
Assumptions for Pricing Model: | ||
Expected term in years | 3 years 7 months 2 days | 3 years 9 months 11 days |
Volatility range for years | 90.00% | 89.00% |
Risk-free interest rate | 1.06% | 1.11% |
Derivative_Liability_and_Fair_5
Derivative Liability and Fair Value Measurements (Additional Information) (Detail) (USD $) | 0 Months Ended | 3 Months Ended | |
Jun. 03, 2014 | Mar. 31, 2015 | Dec. 31, 2014 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | 52,600 | 4,730,992 | |
Convertible Debt | $3,000,000 | ||
Fair Value Of Debt Embedded Conversion Price Adjustment Option | $1,938,988 | ||
Series A Private Placement | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Class of Warrant or Right Outstanding Percentage | 86.00% |
LongTerm_Debt_Components_of_Lo
Long-Term Debt (Components of Long-Term Debt) (Detail) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Debt Instrument [Line Items] | ||
Long term debt | $1,157,106 | $1,217,421 |
Less: Amount Due Within One Year | -80,097 | -128,425 |
Amount Due After One Year | 1,077,009 | 1,088,996 |
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal [Member] | ||
Debt Instrument [Line Items] | ||
Long term debt | -40,074 | -46,399 |
Convertible to shares of the Company's common shares at 2.25, subject to adjustment [Member] | ||
Debt Instrument [Line Items] | ||
Long term debt | 2,037,500 | 2,375,000 |
Unamortized debt discount related to derivative liability associated with above notesb conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988 [Member] | ||
Debt Instrument [Line Items] | ||
Unamortized Debt Discount Related To Derivative Liability | -1,013,551 | -1,348,185 |
Notes Payable [Member] | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member] | ||
Debt Instrument [Line Items] | ||
Long term debt | 130,836 | 186,131 |
Notes Payable [Member] | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member] | ||
Debt Instrument [Line Items] | ||
Long term debt | $42,395 | $50,874 |
LongTerm_Debt_Components_of_Lo1
Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) (USD $) | 0 Months Ended | 3 Months Ended | 12 Months Ended |
Jun. 03, 2014 | Mar. 31, 2015 | Dec. 31, 2014 | |
Debt Instrument [Line Items] | |||
Fair Value Of Debt Embedded Conversion Price Adjustment Option | $1,938,988 | ||
Notes Payable [Member] | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member] | |||
Debt Instrument [Line Items] | |||
Long term debt, fixed interest repayment term | 48 months | 48 months | |
Long term debt repayment starting date | 31-Oct-13 | 31-Oct-13 | |
Long term debt, fixed interest rate | 0.00% | 12.00% | |
Notes Payable [Member] | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member] | |||
Debt Instrument [Line Items] | |||
Long term debt, fixed interest repayment term | 36 months | ||
Long term debt repayment starting date | 15-Jul-13 | 15-Jul-13 | |
Long term debt, fixed interest rate | 12.00% | 12.00% | |
Convertible Senior Secured Notes payable [Member] | |||
Debt Instrument [Line Items] | |||
Long term debt repayment starting date | 3-Jun-17 | 3-Jun-17 | |
Long term debt, fixed interest rate | 5.00% | 5.00% | |
Debt Instrument, Convertible, Conversion Price | 2.25 | 2.25 |
LongTerm_Debt_Aggregate_Maturi
Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Debt Instrument [Line Items] | ||
2015 | $114,088 | |
2016 | 59,143 | |
2017 | 2,037,500 | |
Total Required Principal Payments Exclusive of Debt Discounts | 2,210,731 | |
Total Unamortized Debt Discounts | -1,053,625 | |
Total Net Long-Term Borrowings as of March 31, 2015 | $1,157,106 | $1,217,421 |
Preferred_Stock_Additional_Inf
Preferred Stock (Additional Information) (Detail) (USD $) | 3 Months Ended | 0 Months Ended | |
Mar. 31, 2015 | Jan. 02, 2015 | Dec. 31, 2014 | |
Preferred Stock Shares Authorized | 5,000,000 | 5,000,000 | |
Stock Issued During Period, Value, New Issues | $1,475,000 | ||
Preferred Stock, Liquidation Preference Per Share | $1,000 | ||
Preferred Stock Shares Outstanding | 49,626 | 0 | |
Preferred Stock Shares Outstanding In Percent liquidation or amendment actions | 60.00% | ||
Director Two [Member] | |||
Preferred Stock Shares Outstanding In Percent | 25.00% | ||
Director One [Member] | |||
Preferred Stock Shares Outstanding In Percent | 20.00% | ||
Series A Preferred Stock [Member] | |||
Preferred Stock, Dividend Rate, Percentage | 6.00% | ||
Preferred Stock Shares Outstanding | 12,406 | ||
Series A Preferred Stock [Member] | Director [Member] | |||
Preferred Stock Shares Outstanding In Percent | 40.00% | ||
Series A Preferred Stock [Member] | Corporation [Member] | |||
Stock Issued During Period, Shares, New Issues | 49,626 | ||
Shares Issued, Price Per Share | $500 | ||
Conversion of Stock, Description | Each share of Series A Preferred Stock is convertible, at the option of the Series A Purchaser, into 100 shares of the Companys common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations). | ||
Stock Issued During Period, Value, New Issues | 24,813,000 | ||
Payments of Stock Issuance Costs | $222,000 |
Stock_Warrants_Changes_in_Warr
Stock Warrants (Changes in Warrants) (Detail) | 3 Months Ended |
Mar. 31, 2015 | |
Class Of Warrant Or Right [Line Items] | |
Warrants Outstanding, Beginning of Period | 5,236,660 |
Exercised During the Period | -4,699,017 |
Issued During the Period | 60,000 |
Expired During the Period | 0 |
Warrants Outstanding, End of Period | 597,643 |
Stock_Warrants_Additional_Info
Stock Warrants (Additional Information) (Detail) (USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Class of Warrant or Right [Line Items] | |
Weighted average term of warrants | 2 years 10 months 24 days |
Weighted average exercise price of warrants per share | $2.56 |
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized | $957,291 |
Warrant [Member] | |
Class of Warrant or Right [Line Items] | |
Fair Value Assumptions, Expected Dividend Rate | 0.00% |
Warrants Issued Aggregate Fair Value | 260,373 |
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized | $61,082 |
Minimum | Warrant [Member] | |
Class of Warrant or Right [Line Items] | |
Fair Value Assumptions, Expected Term | 2 years 9 months 18 days |
Fair Value Assumptions, Expected Volatility Rate | 122.80% |
Fair Value Assumptions, Risk Free Interest Rate | 0.90% |
Maximum | Warrant [Member] | |
Class of Warrant or Right [Line Items] | |
Fair Value Assumptions, Expected Term | 3 years |
Fair Value Assumptions, Expected Volatility Rate | 122.90% |
Fair Value Assumptions, Risk Free Interest Rate | 0.99% |
Stock_Option_Plans_Summary_of_
Stock Option Plans (Summary of Stock Option Activity) (Detail) (USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Number of shares outstanding | |
Outstanding, Beginning Balance | 720,551 |
Granted | 0 |
Exercised | 0 |
Expired or Forfeited | 0 |
Outstanding, Ending Balance | 720,551 |
Weighted Average Exercise Price | |
Outstanding, Beginning Balance | $4.46 |
Granted | $0 |
Exercised | $0 |
Expired or Forfeited | $0 |
Outstanding, Ending Balance | $4.46 |
Exercised Price Range | |
Outstanding, Beginning Balance, lower limit | $1.71 |
Outstanding, Beginning Balance, upper limit | $17.50 |
Granted | $0 |
Exercised | $0 |
Expired or Forfeited | $0 |
Outstanding, Ending Balance, lower limit | $1.71 |
Outstanding, Ending Balance, upper limit | $17.50 |
Stock_Option_Plans_Additional_
Stock Option Plans (Additional Information) (Detail) (USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | |
Weighted average remaining contractual term on unvested options | 6 years 10 months 24 days |
Exercisable Options Outstanding Shares | 304,337 |
Weighted average exercise price per share | $6.95 |
Unvested Options Outstanding, Shares | 416,214 |
Unvested Options Outstanding, Weighted average exercise price | $2.63 |
Unvested Options Outstanding Weighted average remaining life (yrs) | 9 years 3 months 18 days |
Unrecognized stock compensation expense | $957,291 |
Weighted average recognition period | 2 years |
Contractual_Obligations_Additi
Contractual Obligations (Additional Information) (Detail) (USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Contractual Obligation | $66,800 |
Description of Lessor Leasing Arrangements, Operating Leases | The Company leases office and manufacturing space under operating leases that expire on September 30, 2015 through to March 1, 2016. |